688238 Stock Overview
A biotechnology company, focuses on the development of gene therapy vectors in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Obio Technology (Shanghai) Corp., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.60 |
| 52 Week High | CN¥12.32 |
| 52 Week Low | CN¥3.86 |
| Beta | 0.60 |
| 11 Month Change | 4.28% |
| 3 Month Change | 16.42% |
| 1 Year Change | -43.78% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -56.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688238 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 0% | -6.0% | -1.2% |
| 1Y | -43.8% | -31.5% | 3.1% |
Return vs Industry: 688238 underperformed the CN Life Sciences industry which returned -31.5% over the past year.
Return vs Market: 688238 underperformed the CN Market which returned 3.1% over the past year.
Price Volatility
| 688238 volatility | |
|---|---|
| 688238 Average Weekly Movement | 10.1% |
| Life Sciences Industry Average Movement | 10.1% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in CN Market | 12.0% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 688238's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 688238's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 722 | Guodong Jia | www.obiosh.com |
Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, focuses on the development of gene therapy vectors in China. The company provides gene function and gene therapy research, and other CRO services, such as drug target and drug efficacy research. It also offers CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.
Obio Technology (Shanghai) Corp., Ltd. Fundamentals Summary
| 688238 fundamental statistics | |
|---|---|
| Market cap | CN¥3.63b |
| Earnings (TTM) | -CN¥246.61m |
| Revenue (TTM) | CN¥251.68m |
14.4x
P/S Ratio-14.7x
P/E RatioIs 688238 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688238 income statement (TTM) | |
|---|---|
| Revenue | CN¥251.68m |
| Cost of Revenue | CN¥316.36m |
| Gross Profit | -CN¥64.68m |
| Other Expenses | CN¥181.93m |
| Earnings | -CN¥246.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 13, 2024
| Earnings per share (EPS) | -0.38 |
| Gross Margin | -25.70% |
| Net Profit Margin | -97.98% |
| Debt/Equity Ratio | 11.5% |
How did 688238 perform over the long term?
See historical performance and comparison